Archives: Speakers

• Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
  Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
• Demand Planning process management – pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
• Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
• Experience in S&OP, 3PL and Supply Chain Organization projects’ implementation
• Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
• Solid team management skills, as well as Customer Service relationship and management
• Teacher for major Post Graduation Schools – Demand Planning and Procurement/Negotiation areas

CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia’s Logistic Supervisor.

Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

Lisbet Groes, Ph.D., e*MMBS, is Associate Director, Clinical Operations at Ascendis Pharma. With over 25 years in clinical development, she brings deep expertise in global trial execution, including leading Phase III programs in Japan. Lisbet has hands-on experience with CRO selection, PMDA interactions, trial execution, and inspection readiness. She is known for her strategic mindset, cross-cultural collaboration, and ability to foster high-performing sponsor-CRO partnerships.

Clinical Operations professional leader with 18+yrs experience in Clinical Drug Development from both Big Pharma & small immunoncology biotech settings. Motivated by developing medicinal products that improves patient’s quality of life. Key competencies includes but are not limited to ICH-GCP, clinical trial regulations & guidelines, Global Clinical Project Management phase 1-4, CRO outsourcing & management, Sponsor Oversight, Risk Management, Quality & Compliance, People leadership, management & mentoring. Currently leading ongoing immunoncology clinical trials in phase 1 & 2, and phase 3 planning for continued clinical development of key assets.

Expert in tobacco identity and age verification requirements.

Asiyah Nawab, MSc, is an Analyst at GlobalData’s London office with the Immunology team. She is involved in the production of in-depth forecasting reports, opportunity assessments, and competitive landscape analysis reports for immunology-related areas. Additionally, Asiyah has extensive research experience in the field of Pharmaceutics, with her research in the encapsulation of drugs within microparticles using emulsion electrospraying, supplemented through in vitro bacterial studies. Asiyah holds a Master of Science in Pharmaceutics from University College London (UCL), and a Bachelor’s degree in Biochemistry from King’s College London.

Chris has over 25 years of experience in the pharmaceutical industry. Over the past 10 years, he has focused on Market Access, Pricing, and Health Economics and Outcomes Research (HEOR), particularly in oncology. He is the Head of Market Access, Pricing, and HEOR for ex-US countries at Immunocore, a small biotech company based in Oxford (UK) and Rockville (USA). Chris is responsible for negotiating reimbursement and access across more than 30 countries.

Immunocore, which originated from Oxford University over 25 years ago, recently launched its first oncology medicine, tebentafusp, for the treatment of a rare cancer with no standard of care and a short life expectancy. The exceptional achievements of Immunocore and tebentafusp were recognised with the prestigious Prix Galien awards in both France and Germany. The launch is regarded as one of the most successful first launches for a biotech company.

Prior to joining Immunocore, Chris supported oncology efforts at AstraZeneca. Before moving into Market Access, he worked in research at GSK and SmithKline Beecham, and in pathology within the UK NHS. Chris holds a master’s degree in Economic Evaluation in Healthcare and a PhD in Biochemistry.

Beth Chamblin has 25 years of experience in Pharmaceutical/BioPharmaceutical development, including over 15 years in global clinical project management and 4 years in oncology project management. At IQVIA Biotech, she specializes in strategic oversight of late-phase global clinical programs, supporting emerging biotech companies. Beth has managed global Phase I-III studies across multiple regions and has expertise in novel trial designs. She also leads a team of 10 project managers/directors, providing mentoring and support. Her broad experience allows her to align each study with a company’s long-term goals, ensuring project success.